R.S.Abdellatif, H., G. Zhang, X. Wang, D. Xie, J. T.S.Irvine, J. Ni, and C. Ni,
"Boosting photocatalytic oxidation on graphitic carbon nitride for efficient photocatalysis by heterojunction with graphitic carbon units",
Chemical Engineering Journal, vol. 370, pp. 875–884, 2019.
R.S.Abdellatif, H., G. Zhang, D. Xie, JiupaiNia, and ChengshengNia,
"Ionic Salt-Mediated Tuning of the Morphology and Band Structure of Graphitic Carbon Nitride for NO Removal under Visible Light",
ACS Applied Nano Materials, vol. 4, issue 3, pp. 2828 - 2839, 2021.
R.S.Hafez, R. Ramdan, and S. S. El‑Khiyami,
"Investigation of structural, optical, magnetic, and electrical properties of PMMA doped with magnetite nanoparticles",
J Mater Sci: Mater Electron , vol. 32, pp. 14557–14568, 2021.
RA, R., F. MM, G. HI, and S. N,
"1- T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo.",
Exp Dermatol, vol. 23, issue 4, pp. 283-286, 2014.
RA, S., A. HR, S. SK, F. IO, S. S, and A. AI,
"Targeting E2F1 and c-Myc expression by microRNA-17-5P represses interferon-stimulated gene MxA in peripheral blood mononuclear cells of pediatric lupus erythematous patients",
Disco Med, vol. 19 , issue 107, pp. 419-25, 2015.
RA, E. - A., H. F, A. - T. H, S. EM, A. - W. AH, A. H. A, S. M, E. - S. A, and A. - T. T.,
"Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy.",
Cancer Biol Ther., vol. 16, issue 7, pp. 1056-70, 2015.
RA, W., P. E, R. CR, S. SK, W. RA, C. JE, P. I, S. NA, and M. L. BA,
"GABA B receptor-modulated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline",
Neuroscience, vol. 213, pp. 154-60, 2012.
RA, A., K. D, E. S. R, E. SM, S. GH, Y. SM, and H. RE,
"• CD209-336A/G promotor polymorphism and its clinical associations in sickle cell disease Egyptian Pediatric patients",
Hematol Oncol Stem Cell Ther , vol. 11, pp. 75– 81, 2018.
Raad, I. I., A. - M. Chaftari, H. A. Torres, E. M. Ayoub, L. I. Narouz, J. Bartek, and R. Hachem,
"Challenge of hepatitis C in Egypt and hepatitis B in Mauritania",
World J Hepatol, vol. 10, issue 9, 2018.
AbstractEgypt has one of the highest prevalence rates of hepatitis C virus (HCV) in the world, mostly with genotype 4 that is highly associated with severe fibrosis. As a consequence, hepatocellular carcinoma has become the leading cause of cancer in this country. Mauritania is a highly endemic area for hepatitis B virus (HBV). HBV and HCV could both be iatrogenically transmitted through infected blood products, infected needles, and medical equipment improperly sterilized. Adequate and efficient healthcare and public health measures with good surveillance programs, access for screening, prevention strategies, and successful treatment are needed to halt the spread of these diseases. Herein, we have reviewed the epidemiology, modes of transmission, predisposing factors, and novel treatment modalities of these viruses. We have proposed practices and interventions to decrease the risk of transmission of HCV and HBV in the affected countries, including strict adherence to standard precautions in the healthcare setting, rigorous education and training of patients and healthcare providers, universal screening of blood donors, use of safety-engineered devices, proper sterilization of medical equipment, hepatitis B vaccination, as well as effective direct-acting antiviral agents for the treatment of HCV.